Professor Barry Furrow gave a presentation at the Loyola University Chicago School of Law’s 10th Annual Symposium on Health Law and Policy on Oct. 28.
Furrow discussed “The CRISPR-Cas 9 Tool of Gene Editing: Cheaper, Faster, Riskier?” at the symposium, which focused on innovations and incentives in life sciences. He joined colleagues from Northwestern University and the University of Houston on a panel that explored “Scientific, Regulatory and Ethical Issues Surrounding Gene Editing Technology.
The director of the law school’s Health Law program, Furrow is the lead author of “Health Law—Cases, Materials and Problems,” the leading casebook in the field, now in its 7th edition.